Find clinical trials for COVID-19 in Dallas, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections

Communicable Diseases

Coronavirus Infections

Pneumonia

Human Influenza

Post-Acute COVID-19 Syndrome

Respiratory Distress Syndrome

COVID-19 trials near Dallas, TX, USA:

Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress

This is a Phase 2 study to assess COVI-MSC in the setting of current standard of care in hospitalized subjects with RT-PCR confirmed SARS-CoV-2 (COVID...

Enrolling

Covid19

Drug: Placebo

Biological: COVI-MSC

Phase 2

Sorrento Therapeutics

Mesquite, Texas, United States and 5 other locations

AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...

Active, not recruiting

COVID-19

Biological: Placebo

Biological: Remdesivir

Phase 3

National Institute of Allergy and Infectious Diseases (NIAID)

Dallas, Texas, United States and 123 other locations

SPI-1005 Treatment in Moderate COVID-19 Patients

multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and moderate symptoms of COVID...

Invitation-only

Covid19

Corona Virus Infection

Drug: Ebselen

Drug: Placebo

Phase 2

Sound Pharmaceuticals

Dallas, Texas, United States and 6 other locations

SPI-1005 Treatment in Severe COVID-19 Patients

multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and severe symptoms of COVID...

Invitation-only

Covid19

Corona Virus Infection

Drug: Ebselen

Drug: Placebo

Phase 2

Sound Pharmaceuticals

Dallas, Texas, United States and 6 other locations

A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2

A study to investigate the prevention of COVID-19 with VYD222 in adults with immune compromise and in participants aged 12 years or...

Active, not recruiting

COVID-19

SARS-CoV-2

Drug: VYD222 (pemivibart)

Drug: Normal saline

Phase 3

Invivyd

Dallas, Texas, United States and 17 other locations

Study of LAU-7b for the Treatment of COVID-19 Disease in Adults (RESOLUTION)

A randomized, double-blind, placebo-controlled Phase 2/3 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patient...

Active, not recruiting

COVID-19 Disease

Drug: Placebo oral capsule

Drug: LAU-7b

Phase 2, Phase 3

Laurent Pharmaceuticals

Dallas, Texas, United States and 28 other locations

A Study of mRNA-1283.222 Injection Compared With mRNA-1273.222 Injection in Participants ≥12 Years of Age to Prevent COVID-19 (NextCOVE)

The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...

Active, not recruiting

COVID-19

Biological: mRNA-1273.222

Biological: mRNA-1283.222

Phase 3